The precise relationship between mutations in CDKN2A and pancreatic cancer is unknown, but pancreatic cancer has predominantly been reported in Swedish, Italian, Dutch and North American CM families [9,18], and mainly with mutations affecting ankyrin repeats 3 and 4 [19]. This evidence concerns the gene CDKN2A and pancreatic neoplasm.